Logo 1 Logo 2

Investigational Drug Details

Drug ID: D025
Drug Name: Pyridoxal
Synonyms:
Type: small molecule
DrugBank ID: DB00147
DrugBank Description: The 4-carboxyaldehyde form of vitamin B 6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. [PubChem]
PubChem ID: 1050
CasNo: 66-72-8
Repositioning for NAFLD: Yes
SMILES: CC1=NC=C(CO)C(C=O)=C1O
Structure:
InChiKey: RADKZDMFGJYCBB-UHFFFAOYSA-N
Molecular Weight: 167.162
DrugBank Targets: Pyridoxal kinase
DrugBank MoA: Pyridoxal is the precursor to pyridoxal phosphate. Pyridoxal 5'-phosphate is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA).
DrugBank Pharmacology: Pyridoxal principally in the form of the coenzyme pyridoxal 5'-phosphate, is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA).
DrugBank Indication: Pyridoxal is one of the natural forms available of vitamin B6, therefore, it is used for nutritional supplementation and for treating dietary shortage or imbalances.
Targets:
Therapeutic Category:
Clinical Trial Progress:
Latest Progress: